RayzeBio, a Bristol Myers Squibb affiliate, seeks a Head of Global Radiopharmaceutical Diagnostic Development to lead end-to-end diagnostic programs (PET/SPECT) from nomination to regulatory approval. You’ll shape development strategy, ensure compliance, and drive cross-functional collaboration across US, Canada, EU, APAC, and Australia/New Zealand.
This role requires 10+ years in radiopharmaceuticals, global regulatory execution, and proven leadership in a highly regulated environment.
#J-18808-LjbffrGlobal Head of Radiopharmaceutical Diagnostics in Remote at Unknown Company
This position is listed as full time and onsite.